CNSL.L LSE
Cambridge Nutritional Sciences plc
1W: +9.7%
1M: -8.1%
3M: -2.9%
YTD: -15.0%
1Y: -47.7%
3Y: -29.2%
5Y: -96.8%
£1.50 ($0.02)
-0.05 (-3.23%)
Weekly Expected Move ±14.2%
£1
£1
£2
£2
£2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$8M
-14.8% ▼
5Y CAGR: -3.2%
Gross Profit
$5M
-17.2% ▼
5Y CAGR: -4.5%
Operating Income
-$640K
-19.6% ▼
Net Income
$2M
+577.4% ▲
EPS (Diluted)
$0.01
+571.4% ▲
EBITDA
$2M
+3111.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $7M | $9M | $8M | $10M | $8M |
| YoY Growth | -30.6% | +25.3% | -11.6% | +29.5% | -14.8% |
| Cost of Revenue | $3M | $4M | $4M | $4M | $3M |
| Gross Profit | $4M | $5M | $3M | $6M | $5M |
| Gross Margin | 58.6% | 55.6% | 42.0% | 61.9% | 60.1% |
| R&D Expenses | $133K | $343K | $274K | $343K | $433K |
| SG&A Expenses | $5M | $6M | $6M | $7M | $5M |
| Operating Expenses | $4M | $5M | $6M | $7M | $6M |
| Operating Income | -$488K | -$582K | -$3M | -$535K | -$640K |
| Operating Margin | -7.2% | -6.8% | -36.8% | -5.5% | -7.7% |
| Interest Expense | $78K | $21K | $13K | $22K | $17K |
| Income Before Tax | -$546K | -$950K | -$3M | -$745K | $2M |
| Tax Expense | -$931K | $459K | -$80K | -$417K | $0 |
| Net Income | -$2M | -$11M | -$4M | -$328K | $2M |
| Net Margin | -30.9% | -132.7% | -51.2% | -3.4% | 18.8% |
| EPS (Diluted) | $-0.01 | $-0.06 | $-0.02 | $-0.00 | $0.01 |
| EBITDA | $418K | -$382K | -$3M | -$73K | $2M |
| Shares Outstanding | 177M | 183M | 231M | 238M | 238M |